Congress Subpoenas Martin Shkreli To Testify On Drug Price Increase A House committee subpoenaed former drug CEO Martin Shkreli to attend a hearing on drug prices and testify on his former firm’s decision to increase a critical drug's price by over 5,000 percent. Whether Shkreli will appear remains to be seen. by Katrina Pascual
Healthy Living/Wellness US Senate Panel To Investigate Valeant, Turing Drug Price Hike by Katherine Derla
Healthy Living/Wellness US Prescription Drug Prices Should Reflect Value They Bring To Patients, Says Expert Panel by Katrina Pascual
Xi Jinping Warns Against Chip Restrictions During Talks with Dutch PM Rutte: 'No Force Can Stop China's Progress'
Researchers Achieve Record Data Transmission Speed, 4.5 Million Times Faster Than Average Home Broadband